Adithya K. Yadalam, MD, MSc

@akyadalam

Emory Cardiology Fellow. Enthusiast of all things Western classical music, literary realism, and cardio-oncology.

Atlanta, GA Joined June 2020

316 Following 195 Followers 73 Posts

Latest posts 5

Adithya K. Yadalam, MD, MSc @akyadalam Sep 8

Proud to see this work shared by @JACCJournals. CVD is the leading cause of death in men with prostate cancer, yet many receive GnRH-agonist ADT without an evidence-based cardioprotective strategy. Statins may soon change that. Grateful to our REVELUTION participants and team.

JACC Journals @JACCJournals Sep 8

Can statins mitigate GnRH agonist-induced #atherosclerosis? 🫀

New #JACCCardioOnc REVELUTION analysis shows baseline statin use slowed dangerous noncalcified plaque progression from leuprolide in prostate cancer jacc.org/doi/10.1016/j.…

@sagarapatel @marly_van_assen @akyadalam

View quoted post on X

Adithya K. Yadalam, MD, MSc @akyadalam Aug 24

Honored to have been asked to write an editorial on this important topic: the CKM-to-cancer axis.

Now in @JACCJournals CardioOncology, CKM stage tracks with cancer risk in the UK Biobank, and -omics mediators tell a stage-ordered immune story.

jacc.org/doi/10.1016/j.…

www.jacc.org The Cardiometabolic-to-Cancer Axis: Molecular Insights From Cardio-Kidney-Metabolic Syndrome Staging

Adithya K. Yadalam, MD, MSc @akyadalam Aug 18

Now in @JACCJournals CardioOncology: statins may blunt the cardiotoxicity of the most-used prostate cancer drug. In this REVELUTION secondary analysis, leuprolide-treated men taking statins had coronary plaque progression similar to relugolix-treated men.

jacc.org/doi/10.1016/j.…

www.jacc.org Statin Use Attenuates Leuprolide-Associated Coronary Atherosclerosis Progression: A Secondary...

Adithya K. Yadalam, MD, MSc @akyadalam Jul 30

Inspiring read and clear articulation of where cardio-oncology must go next: from surveillance-driven management of heterogeneous cardiotoxicity syndromes to mechanism-based science. Grateful to be involved in this field during this exciting time.

Javid Moslehi @CardioOncology Jul 30

I’ve built #CardioOnc programs at BWH/Dana-Farber, Vanderbilt, and UCSF, & trained the next generation. We’ve made tremendous progress but I’m increasingly concerned about where the field is headed. More in my new @JAMACardio Viewpoint. @Barbara_Casadei jamanetwork.com/journals/jamac…
View quoted post on X

Adithya K. Yadalam, MD, MSc @akyadalam Jul 13

Honored to have been selected as the Senior Fellow Representative for the American College of Cardiology Cardio-Oncology FIT Working Group. I am sincerely thankful to @EKoutroumpakis, @RCH_MD, @DSadlerMD, and the entire ACC Cardio-Oncology Section for this wonderful opportunity!